Directory
>
Greg Oehrtman
Greg Oehrtman
VP of Technical Operations | AVEO Oncology
Boston, Massachusetts, United States
Greg Oehrtman
Summary
Greg Oehrtman is an accomplished Vice President of Technical Operations at Aveo Oncology, with extensive experience in drug development and manufacturing across both small and large molecules. He specializes in formulation development and clinical supply chain logistics, leading cross-functional teams to bring innovative pharmaceutical products to market. With a strong background in regulatory submissions and project management, he has spearheaded the launch of various clinical and commercial products, including injectable and oral dosage forms. Greg's expertise extends to advanced technologies such as controlled-release formulations and device development, making him a key player in the biotech industry. He holds a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology, which underpins his technical acumen. In addition to his leadership role, he has contributed to multiple publications in the field, reflecting his commitment to advancing pharmaceutical science.
Greg Oehrtman
Work Experience
VP of Technical Operations at
AVEO Oncology
August 2022 - Present
TechOps, CMC, Supply Chain and Formulation/Device Development Expert at
Oehrtman Consulting
February 2020 - Present
Executive Director, DS & DP Manufacturing and Device, at
Dicerna Pharmaceuticals, Inc.
June 2020 - August 2022
Executive Director, Formulations, Manufacturing, Supply Chain, Device Development, Commercial Launch at
Stealth BioTherapeutics
August 2018 - January 2020
Sr. Director, CMC & TechOps at
Stealth BioTherapeutics
September 2014 - August 2018
Director, Product Development at
AVEO Oncology
April 2011 - September 2014
Assoc. Director, Formulation Development Parenterals at
Amylin Pharmaceuticals
January 2007 - August 2010
Senior Manager, Formulation Development Oral Solids at
IQVIA
April 2000 - December 2006
Scientist, Formulation Development Oral Solids at
Pfizer
March 1998 - March 2000
Greg Oehrtman
Education
Frequently Asked Questions about Greg Oehrtman
What is Greg Oehrtman email address?
Greg Oehrtman's primary email address is *************@stealthbt.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Greg Oehrtman work for?
Greg Oehrtman is a VP of Technical Operations at AVEO Oncology, a company specializing in Commercial physical research.
Where Greg Oehrtman graduated from?
Greg Oehrtman holds a degree in Chemical Engineering from Massachusetts Institute of Technology.
How can I directly contact Greg Oehrtman?
To contact Greg Oehrtman directly, you can use the email address *************@stealthbt.com. Complete contact information is available upon registration with Muraena.
Who is Greg Oehrtman?
Greg Oehrtman is an accomplished Vice President of Technical Operations at Aveo Oncology, with extensive experience in drug development and manufacturing across both small and large molecules. He specializes in formulation development and clinical supply chain logistics, leading cross-functional teams to bring innovative pharmaceutical products to market. With a strong background in regulatory submissions and project management, he has spearheaded the launch of various clinical and commercial products, including injectable and oral dosage forms. Greg's expertise extends to advanced technologies such as controlled-release formulations and device development, making him a key player in the biotech industry. He holds a Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology, which underpins his technical acumen. In addition to his leadership role, he has contributed to multiple publications in the field, reflecting his commitment to advancing pharmaceutical science.
Greg`s contact details
*************@stealthbt.com
*************@stealthpeptides.com
*************@quintiles.com
*********@aveooncology.com
Colleagues
Executive Director, Thought Leader Engagement & Strategic Partnerships
Chief Commercial Officer (CCO)
Executive Director, Head Of Trade & Distribution
Board Member
SVP, General Counsel at AVEO Oncology
Vice President of Sales Oncology Hematology
Retired Pharmaceutical Executive
Advisor to CEO
Executive Director, National Accounts and Federal Markets
Executive Director, Head of Medical Affairs